ZA898989B - Fused heterocyclic derivatives of 1,2,3,4-tetrahydroacridine,a process for their preparation and their use as medicaments - Google Patents

Fused heterocyclic derivatives of 1,2,3,4-tetrahydroacridine,a process for their preparation and their use as medicaments

Info

Publication number
ZA898989B
ZA898989B ZA898989A ZA898989A ZA898989B ZA 898989 B ZA898989 B ZA 898989B ZA 898989 A ZA898989 A ZA 898989A ZA 898989 A ZA898989 A ZA 898989A ZA 898989 B ZA898989 B ZA 898989B
Authority
ZA
South Africa
Prior art keywords
loweralkyl
hydrogen
medicaments
preparation
tetrahydroacridine
Prior art date
Application number
ZA898989A
Other languages
English (en)
Inventor
Gregory M Shutske
M Shutske Gregory
Kevin J Kapples
J Kapples Kevin
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of ZA898989B publication Critical patent/ZA898989B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
ZA898989A 1988-11-25 1989-11-24 Fused heterocyclic derivatives of 1,2,3,4-tetrahydroacridine,a process for their preparation and their use as medicaments ZA898989B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/276,259 US4927820A (en) 1988-11-25 1988-11-25 Fused heterocyclic derivatives of 1,2,3,4-tetrahydroacridine

Publications (1)

Publication Number Publication Date
ZA898989B true ZA898989B (en) 1990-08-29

Family

ID=23055896

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA898989A ZA898989B (en) 1988-11-25 1989-11-24 Fused heterocyclic derivatives of 1,2,3,4-tetrahydroacridine,a process for their preparation and their use as medicaments

Country Status (18)

Country Link
US (1) US4927820A (sv)
EP (1) EP0370449B1 (sv)
JP (1) JPH085881B2 (sv)
KR (1) KR0143235B1 (sv)
AT (1) ATE104298T1 (sv)
AU (1) AU623452B2 (sv)
CA (1) CA2003837C (sv)
DE (1) DE68914600T2 (sv)
DK (1) DK592589A (sv)
ES (1) ES2051965T3 (sv)
FI (1) FI90871C (sv)
HU (1) HU203551B (sv)
IE (1) IE63120B1 (sv)
IL (1) IL92420A (sv)
NO (1) NO173783C (sv)
NZ (1) NZ231494A (sv)
PT (1) PT92389B (sv)
ZA (1) ZA898989B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920117A (en) * 1989-06-09 1990-04-24 Hoechst-Roussel Pharmaceuticals Inc. 4,5,5a,6-tetrahydro-3H-isoxazolo(5,4,3-kl)acridines, pharmaceutical compositions and use
US4994452A (en) * 1989-11-28 1991-02-19 Hoechst-Roussel Pharmaceuticals Inc. Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds
US5112829A (en) * 1989-11-28 1992-05-12 Hoechst-Roussel Pharmaceuticals Inc. Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds
US5861398A (en) * 1996-08-26 1999-01-19 Alanex Corporation Benzoperimidine-carboxylic acids and derivatives thereof
CN101925301B (zh) * 2008-01-25 2014-09-17 高点制药有限责任公司 作为TNF-α合成调节剂和作为PDE4抑制剂的三环化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695573A (en) * 1984-10-25 1987-09-22 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
ATE63903T1 (de) * 1984-10-25 1991-06-15 Hoechst Roussel Pharma 9-amino-1,2,3,4-tetrahydroacridin-1-ol und verwandte verbindungen, verfahren zu ihrer herstellung und verwendung als arzneimittel.
WO1989002739A1 (en) * 1987-10-05 1989-04-06 Pfizer Inc. 4-aminopyridine derivatives
US4920117A (en) * 1989-06-09 1990-04-24 Hoechst-Roussel Pharmaceuticals Inc. 4,5,5a,6-tetrahydro-3H-isoxazolo(5,4,3-kl)acridines, pharmaceutical compositions and use

Also Published As

Publication number Publication date
HU896174D0 (en) 1990-02-28
AU623452B2 (en) 1992-05-14
NO173783B (no) 1993-10-25
FI90871B (sv) 1993-12-31
PT92389A (pt) 1990-05-31
EP0370449B1 (en) 1994-04-13
JPH02193996A (ja) 1990-07-31
KR900007848A (ko) 1990-06-02
NZ231494A (en) 1992-04-28
NO894698L (no) 1990-05-28
NO173783C (no) 1994-02-02
DK592589D0 (da) 1989-11-24
HUT53107A (en) 1990-09-28
DE68914600D1 (de) 1994-05-19
CA2003837A1 (en) 1990-05-25
KR0143235B1 (ko) 1998-07-15
IL92420A0 (en) 1990-07-26
FI90871C (sv) 1994-04-11
HU203551B (en) 1991-08-28
PT92389B (pt) 1995-07-18
CA2003837C (en) 2000-01-18
JPH085881B2 (ja) 1996-01-24
FI895605A0 (sv) 1989-11-23
ES2051965T3 (es) 1994-07-01
ATE104298T1 (de) 1994-04-15
NO894698D0 (no) 1989-11-24
EP0370449A1 (en) 1990-05-30
IL92420A (en) 1994-02-27
DE68914600T2 (de) 1994-09-15
IE63120B1 (en) 1995-03-22
AU4548089A (en) 1990-05-31
IE893758L (en) 1990-05-25
US4927820A (en) 1990-05-22
DK592589A (da) 1990-05-26

Similar Documents

Publication Publication Date Title
CA2024572A1 (en) N-substituted-4-pyrimidinamines and-pyrimidinediamines, a process for their preparation and their use as medicaments
AU589029B2 (en) Alpha-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl) alkanones, a process for their preparation and their use as medicaments
NZ235460A (en) Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl-carbamate derivatives and pharmaceutical compositions
HU9201290D0 (en) 1-/pirido/3,4-b/-1,4-oxazinyl-4-yl/-1h-indole derivatives, process for their production and for the production of medical preparations containing them as active agents
ZA898989B (en) Fused heterocyclic derivatives of 1,2,3,4-tetrahydroacridine,a process for their preparation and their use as medicaments
HU895830D0 (en) Process for the preparation of 1,2,3,4-tetrahydro-1,9-acridine-diamines and pharmaceutical compositions containing said compounds
AU590748B2 (en) Benzo(C)-1,5-naphthyridines, a process and intermediates for their preparation and their use as medicaments
AU619985B2 (en) 4,5,5a,6-tetrahydro-3h-isoxazolo(5,4,3-kl)acridines derivatives, a process for their preparation and their use as medicaments
FI923845A (sv) Förfarande för framställning av terapeutiskt aktiva 1,2,3a,4,5,6-hexahydro/1,3/oxazino/6,5,4-kl/akridinderivat